List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 172 studies with search of: "Hepatitis B, Chronic"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention: Drug: Tenofovir/ & Emtricitabine
2 Recruiting Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
3 Recruiting Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
4 Recruiting Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Telbivudine
5 Recruiting A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir
6 Not yet recruiting A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
Conditions: Hepatitis B, Chronic;   Liver Diseases;   Virus Diseases;   Hepatitis;   Diffuse Hepatic Disease
Intervention: Device: Liquid Acupuncture (Herb Acupoint Injection)
7 Active, not recruiting Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
Condition: Hepatitis B, Chronic
Intervention: Drug: Entecavir
8 Recruiting Adefovir Plus Lamivudine Versus Adefovir Plus Entecavir in Chronic Hepatitis B With Suboptimal Response to Combination of Adefovir Plus Lamivudine
Condition: Hepatitis B, Chronic
Interventions: Drug: Adefovir plus Entecavir;   Drug: Adefovir plus Lamivudine
9 Completed Long-Term Lamivudine Therapy for Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Procedure: Blood Testing;   Procedure: Percutaneous Liver Biopsy;   Procedure: Lamivudine Therapy
10 Recruiting An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: telbivudine
11 Completed KRN7000 in Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: KRN7000
12 Recruiting Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: interferon α plus nucleoside analogue;   Drug: interferon α
13 Recruiting A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: DV-601;   Drug: Entecavir
14 Recruiting A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: peginterferon alfa-2a(40KD) [PEGASYS];   Drug: Adefovir;   Drug: Entecavir;   Drug: Placebo
15 Active, not recruiting Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir;   Drug: Entecavir + Tenofovir
16 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a (40KD) [PEGASYS]
17 Withdrawn Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Lamivudine;   Drug: Telbivudine
18 Terminated A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a (40KD) [PEGASYS]
19 Active, not recruiting A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a (40KD) [PEGASYS]
20 Active, not recruiting Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
Conditions: Hepatitis;   Hepatitis B, Chronic;   Cirrhosis
Interventions: Drug: telbivudine;   Drug: lamivudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services